// App-Quantinova.ai

5199 : An in vivo reporter to quantitatively and temporally analyze the effects of CDK4/6 inhibitor-based therapies in melanoma

Researchers

Presenter

  • Jessica L. Teh

Principal Investigators

  • Timothy Purwin

  • Evan J. Greenawalt

  • Inna Chervoneva

  • Allison Goldberg

  • Michael E. Davies

  • Andrew Aplin

Medical Centers

  • Thomas Jefferson University, Philadelphia, PA

  • MD Anderson University of Texas Houston, Houston, TX.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Retinoblastoma

  • Breast cancer

  • Melanoma

  • Solid malignancies

Biomarkers

  • B-Raf proto-oncogene, serine/threonine kinase

  • Cyclin-dependent kinase 4

  • GTPase Nras

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Palbociclib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved